WHO Backs Pfizer’s Paxlovid For High-Risk COVID-19 Patients

But Access Obstacles Remain In Lower-Income Countries

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".